GlassScriptPhysician profile
Rose Kennedy
NPI 1831159987
$524.11
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $82.12.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $95.23 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $74.81 | 2019 | |
| Amgen INC. | $73.63 | 2019 | |
| Biom'Up Sa | $69.21 | 2019 | |
| Hologic Sales and Service, LLC | $60.94 | 2019 | |
| Biom'Up France Sas | $39.17 | 2020 | |
| Avion Pharmaceuticals | $36.31 | 2019-2020 | |
| Exeltis, USA INC. | $24.10 | 2019 | |
| Allergan, INC. | $23.31 | 2019 | |
| Abbvie INC. | $16.02 | 2019 | |
| Roche Diagnostics Corporation | $11.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.